BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products

Core Insights - Bon Natural Life Limited has entered a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. for a total contract value of US$18 million over 24 months, focusing on the distribution of its second-generation Apple Series health products in Greater China [1] - The second-generation Apple Series utilizes advanced low-temperature extraction technology, achieving 80% higher bioactivity compared to its predecessor, enhancing the efficacy of active ingredient extraction [2] - The incorporation of apple polyphenols into protein supplements offers clinically validated benefits, including improved lipid metabolism and enhanced body composition, positioning the product for significant growth potential in the health and wellness market [3] Market Validation and Performance - Early market validation shows comparable apple polyphenol blends generating over $40 million in monthly sales, indicating a strong consumer demand for scientifically validated nutraceutical products [4] - The company’s management is confident in achieving strong market performance due to the competitive advantages of its second-generation formulation [4] - The Chairman and CEO of BON emphasized the company's capability to lead in the metabolic health segment, expecting significant revenue and profit growth across nutraceutical and functional food markets [5]